You are here

  • Home
  • Archive
  • Volume 8, Issue 11
  • Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol

Article metrics

Article menu

Download PDFPDF

XML
Diabetes and endocrinology
Protocol
Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol

 

Online download statistics by month:

Online download statistics by month: November 2018 to October 2024

AbstractFullPdf
Nov 2018595589161
Dec 201826025733
Jan 201911010226
Feb 2019827518
Mar 2019807728
Apr 2019686527
May 2019777230
Jun 2019646128
Jul 2019585624
Aug 2019565116
Oct 2019524918
Nov 2019373619
Dec 2019202010
Jan 2020393518
Feb 2020252317
Mar 2020242313
May 2020302619
Jun 2020222216
Jul 2020242220
Aug 2020201715
Sep 2020352831
Oct 2020322920
Nov 2020262415
Dec 2020232013
Jan 2021423732
Feb 202116149
Mar 2021262616
Apr 2021232319
May 2021222215
Jun 2021161613
Jul 2021161511
Aug 2021333014
Sep 2021282713
Oct 2021171623
Nov 2021111118
Dec 2021201910
Jan 2022222211
Feb 2022191712
Mar 2022272422
Apr 202216159
May 2022211819
Jun 2022242213
Jul 202216166
Aug 2022201610
Sep 20229810
Oct 202214126
Nov 2022151413
Dec 202225243
Jan 2023383612
Feb 202316168
Mar 2023242311
Apr 2023181710
May 2023201614
Jun 202312111
Jul 202319139
Aug 202319173
Sep 202314148
Oct 202317156
Nov 202321179
Dec 2023252110
Jan 2024424214
Feb 202417168
Mar 2024403813
Apr 202422208
May 202418174
Jun 20241096
Jul 202415149
Aug 2024977
Sep 202415139
Oct 2024541
Total279326391142